Ultragenyx Pharmaceutical Inc. buy Wells Fargo & Company
Start price
20.10.25
/
50%
€29.20
Target price
20.10.26
€55.74
Performance (%)
-26.92%
Price
15.04.26
?
Summary
This prediction is currently active. The price of Ultragenyx Pharmaceutical Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -26.92%. This prediction currently runs until 20.10.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 0.505% | 0.505% |
| iShares Core DAX® | 4.244% | 2.864% |
| iShares Nasdaq 100 | 4.890% | 2.814% |
| iShares Nikkei 225® | 9.397% | 7.826% |
| iShares S&P 500 | 3.528% | 1.950% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $65.00 price target on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€17.00
30.12.25
30.12.25
€38.21
30.12.26
30.12.26
25.53%
15.04.26
15.04.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€26.00
10.07.25
10.07.25
€55.35
10.07.26
10.07.26
-17.92%
15.04.26
15.04.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€41.80
20.12.24
20.12.24
€84.54
20.12.25
20.12.25
-32.06%
21.12.25
21.12.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.20
02.08.24
02.08.24
€68.71
02.08.25
02.08.25
-46.75%
03.08.25
03.08.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€37.60
08.12.23
08.12.23
€66.97
08.12.24
08.12.24
23.94%
09.12.24
09.12.24